Participants (N=3632) were randomly assigned 2:1 to receive either a 105mg intramuscular (IM) single dose of clesrovimab or placebo ... chair of the Department of Infectious Diseases at St. Jude’s ...
Some results have been hidden because they may be inaccessible to you